Form 4: Boston Scientific Director Wichmann Receives Equity Award

Director David S. Wichmann of Boston Scientific Corp. received an annual equity award in the form of restricted stock.

Summary

• David S. Wichmann, a director at Boston Scientific Corp, reported a transaction on May 8, 2025.
• Wichmann acquired 2,081 shares of common stock through an annual equity award.
• The shares were valued at $0.00 per share.
• This acquisition increased Wichmann's total holdings to 41,582 shares of common stock.
• The equity award is in the form of restricted stock that vests in full upon the next annual meeting of stockholders.
• The value of the award is $215,000 divided by the closing price of common stock on the date of grant.

Sentiment

Score: 7

Explanation: The document reflects a routine equity award to a director, which is generally viewed positively as it aligns management's interests with shareholders. There are no indications of negative news or concerns.

Positives

• The equity award to a director signals confidence in the company's future performance.

Future Outlook

The restricted stock vests in full upon the next annual meeting of stockholders, aligning the director's interests with those of the shareholders.

Industry Context

Equity awards are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders, incentivizing them to work towards increasing shareholder value.

Next Steps

• The restricted stock will vest upon the next annual meeting of stockholders.

Key Dates

Keywords

equity award, restricted stock, Form 4, director, Wichmann, Boston Scientific, BSX, common stock